fasudil: Clinical Trials

3 trials of fasudil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 22Recruiting 1, Unknown 1

Follow fasudil: new trials by email Literature Review of fasudil trials Research Report on fasudil

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Fasudil hydrochloride and PD1 inhibitor combined with androgen deprivation therapy, Placebo combined with androgen deprivation therapy, radical prostatectomy - Prostate CA
Phase 2 / Phase 3Recruitingbaotai Liang832025-02-162025-11-18
Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients
injection bevacizumab, injection Combined Bevacizumab and Fasudil - Retinal Vein Occlusion
Phase 2 / Phase 3UnknownShahid Beheshti University of Medical Sciences362018-01-012018-01-05
A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Fasudil - Raynaud, Scleroderma
Phase 3CompletedJohns Hopkins University172007-04-012014-11-04

Conditions studied

Raynaud Disease (1)  ·  Retinal Vein Occlusion (1)  ·  Scleroderma, Diffuse (1)

Sponsors

Johns Hopkins University (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  baotai Liang (1)

Countries

China (1)  ·  Iran (1)  ·  United States (1)

Top investigators

Fredrick M Wigley, M.D. (1)